Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II multicenter randomized double-blind trial of QuBai BaiReSi tincture plus NB-UVB in stable vitiligo
CTR20211100Phase 2Completed
- Sponsor
- Xinjiang Uygur Pharmaceutical Co., Ltd.
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Qubai Bairesi Tincture in Vitiligo, sponsored by Xinjiang Uygur Pharmaceutical Co., Ltd.. Started May 2021; status: completed.
02
Drugs
Qubai Bairesi Tincture
03
Conditions
Vitiligo
Beyond the preview
Go deeper on CTR20211100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211100.